Delivery Order SPE2DB22D3501-SPE2DB24FVT43

Award Date 5/22/24
Potential Completion Date 6/13/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of Veklury (remdesivir) with a potential value of $6,809.20. The award has a completion date of February 28, 2024. Amerisourcebergen Drug Corp, based in Conshohocken, Pennsylvania, is a for-profit prime contractor that provides a wide range of pharmaceutical products and medical supplies to government...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The contract is valued at $17,023.00 and has a completion date of August 16, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, through its extensive supply chain and distribution capabilities, will provide this critical antiviral medication to support various...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,754.64, is for the delivery of the drug VEKLURY (Remdesivir) 100 mg vials. It is a firm fixed-price contract with a completion date of June 2, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a ceiling value of $2,377.32 and a period of performance through May 14, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of the antiviral drug Veklury (Remdesivir). The $13,618.40 contract has an ultimate completion date of April 17, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
This contract award to AmerisourceBergen Drug Corp is a delivery order worth $6,809.20 for the supply of Veklury (remdesivir) 100 mg vials. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The contract has an ultimate completion date of October 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This award is likely part of a larger Indefinite Delivery Contract (IDC) the company holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $20,427.60 firm fixed price contract has an ultimate completion date of October 29, 2024. This award is a task order under AmerisourceBergen's Indefinite Delivery Contract valued up to $999,999,999 with DLA Troop Support Medical for a wide range of pharmaceutical and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of VEKLURY (remdesivir) 100 mg vials. The firm fixed price contract has a potential value of $27,236.80 and a completion date of March 5, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, which serves as...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 100 milligram vials of the COVID-19 treatment medication Veklury (Remdesivir) with a potential value of $13,618.40 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Veklury (Remdesivir) 100 mg vials, a treatment for COVID-19. The contract has a ceiling value of $6,809.20 and runs through July 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVT43
    Delivery Order

This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $6,809.20, is for the delivery of the pharmaceutical product Veklury (remdesivir) 100 mg vials. The contract has a completion date of June 13, 2024.

AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This current delivery order is likely part of that larger IDC.

The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis, highlighting AmerisourceBergen's competitive position in the federal pharmaceutical supply market.

Generated 8/21/24, 7:14 PM